Analyst Josh Jennings of TD Cowen reiterated a Buy rating on Stereotaxis (STXS – Research Report), retaining the price target of $5.00.Stay ...

Brain surgery, like rocket science, has become a byword in popular culture for an intellectually challenging and risky ...

PureCycle Technologies is facing financial struggles with zero sales in Q3 2024, limited offtake agreements, and escalating ...

After hours: January 21 at 6:41:44 PM EST Loading Chart for ATRC ...